Dennis Crowley, VP of Corporate Development, Covidien
Dennis Crowley is the Vice President of Corporate Development & Licensing at Covidien; a $10B publicly traded medical device company based in Massachusetts. Covidien was previously known as Tyco Healthcare before separating from Tyco International in June 2007. Dennis has been with Covidien for over 3 years and, before then, he was with Tyco International for 12 years in various roles within Business Development and Operations.
Dennis began his career at Tyco in Corporate Strategy and Business Development for 3 years working on strategic plans and acquisitions. He then spent 5 years in Europe as Director of M&A for the Flow Control division. During this tenure, the Flow Control division grew from $100M in revenue to over $2.5B globally. Dennis returned to Tyco International as Senior Director of M&A for 2 years and then spent 2 years as VP of Operational Excellence for Tyco Engineered Products and Services, a segment of Tyco.
Dennis has led or worked on over 50 acquisitions and divestitures in all major regions of the world (e.g. North America, Europe, and Asia) in his career. The final consideration of these transactions ranges from $10M to over $5B.
Founder
Dennis Crowley
VP of Corporate Development, Covidien
Chairman,
Henry Crown and Company
President and CEO
Member, MedVenture Associates
Partner, US Venture Partners
Managing Director, Essex Woodlands
Health Ventures
Senior Partner,
Wilson, Sonsini, Goodrich & Rosati
Director of Finance
